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We have compared the efficacies of three general primer pairs for the detection of human papillomavirus
(HPV) DNA in formaldehyde-fixed paraffin-embedded carcinomas. The use of these primer pairs leads to
underestimates of the HPV prevalence (GP5/6, 61.1%; CPI/IIG, 57.4%; MY09/11, 46.9%; combined, 72.8%). The
efficacy of each primer pair seemed to be inversely correlated to the length of the amplimer produced. By using
newly developed type-specific primer pairs (amplimer length, approximately 100 bp), an increase in HPV DNA
detection (87.6%) was found.
There is strong evidence to link the presence of human
papillomaviruses (HPV) to the development of cervical cancer
(11). The presence of HPV DNA in over 90% of carcinomas of
the uterine cervix has been established by PCR (12, 18, 20).
Ideally, one primer pair would suffice for PCR amplification of
all mucosatropic HPV types (6, 9, 14, 16, 20). As paraffin-
embedded material is the main source for retrospective studies
using PCR, the efficacies of three general primer systems with
archival tissues were investigated, along with those of HPV
type-specific (TS) primer pairs and sequence analysis.
Paraffin-embedded tissues from 162 women treated for
squamous cell cervical carcinomas at the Department of Ob-
stetrics and Gynaecology, University Hospital, Groningen, The
Netherlands, were available. DNA was extracted from 10-mm
sections by deparaffination and digestion with proteinase K, as
described by Wright and Manos (19). Adjacent sections were
hematoxylin and eosin stained and assessed for the presence of
tumor cells.
All oligonucleotide primers were obtained from Pharmacia,
Woerden, The Netherlands. The primers used were the MY09-
MY11 set (MY09/11) (9), the GP5-GP6 set (GP5/6) (14), and
the CP-I–CP-IIG set (CPI/IIG) (16) (Table 1). As a control for
DNA extraction, b-globin primers PC03 and PC04 (13) were
used. Conventional TS primers were used for HPV type 16
(HPV-16), -18, -31, and -33 (4, 10, 18). In addition, for the
detection of HPV-16, -18, -31, and -33 DNAs, supplementary
primer pairs (new TS primers) spanning shorter DNA se-
quences were constructed (Table 2). PCR amplification was
performed by the method of Saiki et al. (13). The final 100-ml
PCR mixture contained a 10-ml sample, 10 mM Tris-HCl (pH
TABLE 1. Specifications of oligonucleotides used as primers and probes for general HPV detection by PCR
Primer or probe Sequence (59–39)a Targetb Amplimer length (bp) Reference
Primers
MY09 CGTCCMARRGGAWACTGATC L1 452 9
MY11 GCMCAGGGWCATAAYAATGG
GP5c TTTGTTACTGTGGTAGATAC L1 155 14
GP6 ACTAAATGTCAAATAAAAAG
CP-I TTATCAWATGCCCAYTGTACCAT E1 188 16
CP-IIG ATGTTAATWSAGCCWCCAAAATT
PC03 ACACAACTGTGTTCACTAGC b-Globin 13
PC04 CAACTTCATCCACGTTCACC
Probesd
GP1 CTGTTGTTGATACTACACGCAGTAC 17
GP2 CTGTGGTAGATACCACWCGCAGTAC 17
PR-G AGCAYTRTATTGGTATMGAACAGG 16
aM, A1C; R, A1G; S, G1C; W, A1T; Y, C1T.
b L1, HPV late structural protein 1; E1, HPV early protein 1.
c Used in combination with random prime-labelled probe GP5/6.
d GP1 and GP2 are general probes used with MY09/11, and PR-G is a probe for genital HPV used with CPI/IIG.
* Corresponding author. Mailing address: Department of Immunol-
ogy & Infectious Diseases, Diagnostic Centre SSDZ Delft, P.O. Box
5010, 2600 GA Delft, The Netherlands. Phone: 31 152603050. Fax: 31
152604594.
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9.0), 50 mM KCl, 2.5 mM MgCl2, 0.1% Triton X-100, 0.01%
gelatin, 200 mM deoxynucleoside triphosphates, 50 pmol of
each primer, and 0.25 U of SuperTaq (Sphaero Q, Cambridge,
United Kingdom), except for the MY09/11 PCR, in which 0.5
U of SuperTaq was used. The standard PCR conditions were 1
min at 958C, 1 min at the annealing temperature, and 2 min at
728C for 40 cycles. After PCR, 25 to 30 ml of all samples was
run on a 2% agarose gel; gels were blotted (Hybond N1;
Amersham, Little Chalfont, United Kingdom) and hybridized
with the appropriate probe (Tables 1 and 2). Blots were
washed twice for 15 min in 23 SSC (13 SSC is 0.15 M NaCl
plus 0.015 M sodium citrate)–0.1% sodium dodecyl sulfate.
For all samples positive in general PCRs and negative in both
TS PCRs, the general PCR amplimer bands were sequenced by
the protocol of the manufacturer of the T7 sequencing kit
(Pharmacia).
All patients were positive in the b-globin PCR (100-bp DNA
fragment). Of 162 carcinomas, 118 (72.8%) were positive for
HPV DNA; 99 (61.1%) were positive with GP5/6, 93 (57.4%)
were positive with CPI/IIG, and 76 (46.9%) were positive with
MY09/11 (Table 3). All tissue samples were also tested with
conventional TS primer pairs. Of 118 carcinomas positive with
one or more general primer pairs, 59 carcinomas were positive
with conventional TS primers; the remaining 59 carcinomas
were still untypeable. None of the tissue samples negative with
general primers were positive with conventional TS primer
pairs. Further evaluation was performed with newly selected
TS primer pairs. By using these new TS primer pairs, 43 of the
59 untypeable carcinomas could be typed. Furthermore, with
these new TS primer pairs, 24 of the 44 carcinomas negative
with all general HPV primer pairs were positive for HPV (19
contained HPV-16 DNA and 5 contained HPV-18 DNA), thus
raising total HPV positivity to 87.6% for this group of 162
cervical carcinomas. In this way, 95 carcinomas were found to
contain HPV-16 DNA, 23 contained HPV-18 DNA, 2 con-
tained HPV-31 DNA, 5 contained HPV-33 DNA, and 1 car-
cinoma was positive for both HPV-16 and -31.
Sixteen carcinomas positive with general primers were still
untypeable; of these, 14 were subjected to sequencing. From
two patients, insufficient amounts of material were available
for sequencing. Other HPV types found in this way were
HPV-6, HPV-34 (twice), HPV-45, HPV-52, HPV-58, HPV-X
(some similarity to HPV-34 [data not shown]), and HPV-X
(some similarity to HPV-18, not reacting with the conventional
or new HPV-18-specific primer pair [data not shown]). Five
carcinomas were HPV-16 positive, and one was HPV-33 pos-
itive; however, they did not react with conventional or new TS
primers.
The results described above show that the use of one general
HPV primer pair with paraffin-embedded tissues grossly un-
derestimates the presence of HPV DNA in the studied popu-
lation. Moreover, even the combination of the three most
widely used primer pairs, MY09/11, GP5/6, and CPI/IIG, still
results in an underestimation of HPV prevalence.
Several authors have reported difficulties in reproducing
PCR results with formaldehyde-fixed tissues (1, 2, 5, 15). Re-
cently, the antagonistic effect of formaldehyde fixation due to
DNA modification, causing the inhibition of PCR amplifica-
tion of longer (.200-bp) amplimers, has been described by
Karlsen et al. (7).
Our results show that the efficiency of the primer pair is
inversely correlated to the length of the amplimer and that the
amplification of a PCR product of less than 200 bp is also
affected by formaldehyde fixation, as the GP5/6 (amplimer
length, 155 bp; positivity, 61.1%) and CPI/IIG (188 bp and
57.4%, respectively) primer pairs do not reach the overall
positivity of 87.6%.
The newly designed TS primers proved to be of great value,
since 72.9% of the general primer-positive untypeable carci-
nomas could be typed. Furthermore, with the new TS primers,
24 of the 44 general HPV PCR-negative carcinomas were
found to contain HPV DNA.
TABLE 2. Specifications of oligonucleotides used as primers and probes for TS HPV detection by PCR
Primer pair or probe Sequence(s) (59–39)a Amplimer length (bp) Reference
Primer pairs
Conventional TS 16 GTGTGTACTGCAAGCAACAG, GCAATGTAGGTGTATCTCCA 395 4
New TS 16 GGTCGGTGGACCGGTCGATG, GCAATGTAGGTGTATCTCCA 96 This study
Conventional TS 18 AAGGATGCTGCACCGGCTGA, CACGCACACGCTTGGCAGGT 217 10
New TS 18 CCTTGGACGTAAATTTTTGG, CACGCACACGCTTGGCAGGT 115 This study
Conventional TS 31 ATGGTGATGTACACAACACC, GTAGTTGAGGACAACTGAC 514 18
New TS 31 GGGATTGTTACAAAGCTACC, CGCTTAGTAGACGTCGTCGC 110 This study
Conventional TS 33 ATGATAGATGATGTAACGCC, GCACACTCCATGCGTATCAG 506 10
New TS 33 CCACCACTGCTTCTTACCTC, ACCATTTTCATCAAATGGGA 114 This study
Probes
TS 16b CAAGAACACGTAGAGAAACCCAGCTGTAAT 4
TS 18 TGGTTCAGGCTGGATTGCGTCGCAAGCCCA 10
TS 31 ACCTGCGCCTTGGGCACCAGTGAAGGTGTG 18
TS 33 CAAATGCAGGCACAGACTCTAGATGGCCAT 10
a For primer pairs, the sequences are given in the order of the 59 primer followed by the 39 primer.
b The new TS 16 primers were used in combination with random prime-labelled HPV-16 E6 probe.
TABLE 3. HPV PCR-positive results of 162 cervical carcinomas
with three general primer sets
PCR result with primer seta No. with
patternGP5/6 CPI/IIG MY09/11
2 2 2 44
1 2 2 11
2 1 2 8
2 2 1 4
1 1 2 23
1 2 1 10
2 1 1 7
1 1 1 55
a Of 162 carcinomas, 118 (72.8%) were positive with at least one primer set.
The total numbers detected by primer sets GP5/6, CPI/IIG, and MY09/11 were
99 (61.1%), 93 (57.4%), and 76 (46.9%), respectively.
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It can be argued, however, that the amplification of these
100-bp amplimers is still hampered by formaldehyde fixation,
as studies using fresh tissue samples commonly report HPV
prevalences well over 90% (8, 12, 18, 20). Alternatively, the
HPVs not detected by the TS primers are types other than
HPV-16, -18, -31, and -33.
In conclusion, general primer pairs are unsatisfactory for the
amplification of HPV DNA from formaldehyde-fixed paraffin-
embedded tissue samples. Therefore, we propose the following
strategy for cervical carcinomas: amplification with new TS
primers (giving approximately 100-bp products), amplification
of TS-negative tissues with CPI/IIG, GP5/6, and/or MY09/11
primer pairs, and subsequent sequencing to detect other HPV
types. At this moment, this should lead to the highest possible
detection of HPV DNA from formaldehyde-fixed paraffin-
embedded carcinomas.
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